Exercise Intervention in Breast Cancer Patients With Treatment-Induced Arthralgia

Completed · Not applicable

Conditions studied: Breast Cancer, Arthralgia

In brief

This is a pilot study of a specifically designed exercise intervention developed for breast cancer patients with aromatase-inhibitor related joint pain.

Key facts

Study ID

NCT01236417

Run by

Roswell Park Cancer Institute

People needed

27

Starts

2010-03-01

Last updated by the study team

2012-04-13

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Post menopausal women with a history of estrogen positive breast cancer who are receiving aromatase inhibitors for at least one month.
• Patients must complain of mild to moderate arthralgia.
• Ability to understand and sign informed consent.
• Patients meet criteria for low to moderate risk for moderate exercise based oon the ACSM guidelines.

You may not qualify if…

• Inability to comply with study requirements.
• Metastatic breast cancer.
• Patients with orthopedic or neuromuscular disorders that preclude participation in exercise.
• Rheumatoid arthritis.
• History of MI, angina or congestive heart failure.
• Pregnant or lactating females.
• Patients that are high risk for moderate exercise based on ACSM risk classification.
• Patients who exceed minimal physical activity recommendations from the US Surgeon General's Report: Accumulation of 30 minutes or more of moderate physical activity on most days of the week.
• Morbidly obese with BMI ≥ 40

Where it is running

• Roswell Park Cancer Institute — Buffalo, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.